We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Siemens and Biosense Webster Extend Catheter Distribution Agreement

By MedImaging staff writers
Posted on 02 Feb 2007
Siemens Medical Solutions (Erlangen, Germany) and Biosense Webster, Inc. More...
(Diamond Bar, CA, USA) announced an extension of their strategic alliance to now give Biosense Webster exclusive worldwide rights to distribute Siemens' Acuson AcuNav ultrasound catheters to interventional cardiologists.

Earlier in 2007, Biosense Webster was granted exclusive distribution rights to market the catheter to electrophysiologists. The Siemens AcuNav ultrasound catheters provide physicians with high-quality diagnostic images and Doppler blood flow data throughout the entire heart during a cardiac catheterization procedure. Approved for marketing in 1999, AcuNav ultrasound catheters are known for state-of-the-art quality.

"The integration of these two industry leaders, both focused on providing high quality intracardiac echocardiography products, will help physicians improve care for the cardiac patient,” said Robert J. Sommer, M.D., New York-Presbyterian Hospital/Columbia University Medical Center (New York, NY, USA). "Clinicians are looking forward to the innovative products that this collaboration will provide to the medical community.”

Biosense Webster is a major player in the electrophysiology and interventional cardiology market and Siemens is an ultrasound industry leader. This expanded strategic alliance will enable both two companies to address the real-time imaging needs of interventional cardiologists.

"We are pleased to extend this strategic alliance with Siemens Medical Solutions Ultrasound Division into the interventional cardiology market. This agreement provides additional opportunities to collaborate with our partners at Siemens to bring to market innovative solutions in electrophysiology and interventional cardiology,” said Roy Tanaka, president, Biosense Webster. "Together, Biosense Webster and Siemens will better serve the needs of cardiologists around the world to help millions of patients each year who suffer from cardiovascular disease.”

Biosense Webster pioneered electrophysiology diagnostic catheters more than 30 years ago and continues to provide advanced diagnostic, therapeutic, and mapping tools.



Related Links:
Siemens Medical Solutions
Biosense Webster

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
External Defibrillator
HeartSave Y | YA
X-Ray System
Leonardo DR mini III
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.